KPT-9274 is a dual NAMPT/p21-activated kinase 4 (PAK4)/inhibitor that decreases the NAD+/NADH ratio in cancer cells, inhibiting tumor growth in sarcoma mice models and RCC [139,159]. Here, PAK4 is linked to sarcoma.